Observational studyResearch and practice in thrombosis and haemostasis2026
Evaluating longitudinal data accuracy in postpartum venous thromboembolism risk assessments: a retrospective observational study.
Observational study in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Venous thromboembolism (VTE) risk assessment (VTERA) tools can be used to guide clinical decisions on postpartum thromboprophylaxis. However, the appropriateness of these decisions depends on the accuracy of the data input into VTERA tools. Objectives: The primary objective was to assess whether the accuracy of postpartum VTE risk assessments differed between the study years (2019-2025), across 9 predefined risk factors. The secondary objectives included evaluating the accuracy of all risk factors and thromboprophylaxis recommendations in a 2025 sample. Methods: In this retrospective observational study, the accuracy of data entered into a postpartum VTERA tool was assessed, through comparison with electronic health record data. Differences in accuracy across study years (2019-2025), for 9 structured risk factors, were evaluated using Poisson regression. For the primary analysis, all deliveries and bookings, with a matched VTERA between January 2019 and August 2025, were included. For the secondary analysis, 283 patients from 2025 were manually reviewed to assess all 23 risk factors and thromboprophylaxis recommendations. Results: Primary analysis included 47,489 deliveries and bookings, with a matched risk assessment. Body mass index was the risk factor with the lowest accuracy overall (94.3%) and remained the lowest across each year. Compared with 2019, postpartum VTE risk factor recording was significantly more accurate in 2020, 2021, 2022, 2023, 2024, and 2025. Secondary analysis showed that 6.0% of risk assessments produced inaccurate thromboprophylaxis recommendations, regarding indication and duration, and 4.9% yielded inaccurate dose recommendations. Conclusion: Future research must focus on enhancing the accuracy of VTE risk assessments. This may involve auto-population of VTERA tools using electronic health record data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.